These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 10022731)

  • 1. Changes in cyclin dependent kinase inhibitors p21 and p27 during the castration induced regression of the CWR22 model of prostatic adenocarcinoma.
    Myers RB; Oelschlager DK; Coan PN; Frost AR; Weiss HL; Manne U; Pretlow TG; Grizzle WE
    J Urol; 1999 Mar; 161(3):945-9. PubMed ID: 10022731
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fatty acid synthase: an early molecular marker of progression of prostatic adenocarcinoma to androgen independence.
    Myers RB; Oelschlager DK; Weiss HL; Frost AR; Grizzle WE
    J Urol; 2001 Mar; 165(3):1027-32. PubMed ID: 11176534
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the effectiveness of adenovirus vectors expressing cyclin kinase inhibitors p16INK4A, p18INK4C, p19INK4D, p21(WAF1/CIP1) and p27KIP1 in inducing cell cycle arrest, apoptosis and inhibition of tumorigenicity.
    Schreiber M; Muller WJ; Singh G; Graham FL
    Oncogene; 1999 Mar; 18(9):1663-76. PubMed ID: 10208428
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormal expression of sex steroid receptors and cell cycle-related molecules in adenocarcinoma in situ of the uterine cervix.
    Lu X; Shiozawa T; Nakayama K; Toki T; Nikaido T; Fujii S
    Int J Gynecol Pathol; 1999 Apr; 18(2):109-14. PubMed ID: 10202666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p27kip1 in prostatic adenocarcinoma.
    Cheville JC; Lloyd RV; Sebo TJ; Cheng L; Erickson L; Bostwick DG; Lohse CM; Wollan P
    Mod Pathol; 1998 Apr; 11(4):324-8. PubMed ID: 9578081
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential expressions of cyclin-dependent kinase inhibitors (p27 and p21) and their relation to p53 and Ki-67 in oral squamous tumorigenesis.
    Choi HR; Tucker SA; Huang Z; Gillenwater AM; Luna MA; Batsakis JG; El-Naggar AK
    Int J Oncol; 2003 Feb; 22(2):409-14. PubMed ID: 12527941
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Osteoclast differentiation is associated with transient upregulation of cyclin-dependent kinase inhibitors p21(WAF1/CIP1) and p27(KIP1).
    Okahashi N; Murase Y; Koseki T; Sato T; Yamato K; Nishihara T
    J Cell Biochem; 2001; 80(3):339-45. PubMed ID: 11135363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contrasting roles of p57(KIP2) and p21(WAF1/CIP1/SDI1) in transplanted human and bovine adrenocortical cells.
    Thomas M; Popnikolov NK; Scott C; Smith JR; Hornsby PJ
    Exp Cell Res; 2001 May; 266(1):106-13. PubMed ID: 11339829
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Loss of the cyclin-dependent kinase inhibitor p27(Kip1) protein in human prostate cancer correlates with tumor grade.
    Guo Y; Sklar GN; Borkowski A; Kyprianou N
    Clin Cancer Res; 1997 Dec; 3(12 Pt 1):2269-74. PubMed ID: 9815624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic impact of cyclin dependent kinase inhibitors p21WAF1, p27Kip1, and p16INK4/MTS1 in adenocarcinomas of the uterine cervix: an immunohistochemical evaluation of expression patterns in population-based material from 142 patients with international federation of gynecology and obstetrics stage I and II adenocarcinoma.
    Alfsen GC; Reed W; Sandstad B; Kristensen GB; Abeler VM
    Cancer; 2003 Nov; 98(9):1880-9. PubMed ID: 14584070
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Androgen receptor regulation of G1 cyclin and cyclin-dependent kinase function in the CWR22 human prostate cancer xenograft.
    Gregory CW; Johnson RT; Presnell SC; Mohler JL; French FS
    J Androl; 2001; 22(4):537-48. PubMed ID: 11451350
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tumor suppression by p27Kip1 and p21Cip1 during chemically induced skin carcinogenesis.
    Philipp J; Vo K; Gurley KE; Seidel K; Kemp CJ
    Oncogene; 1999 Aug; 18(33):4689-98. PubMed ID: 10467416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cell cycle regulators in bladder cancer: a multivariate survival study with emphasis on p27Kip1.
    Korkolopoulou P; Christodoulou P; Konstantinidou AE; Thomas-Tsagli E; Kapralos P; Davaris P
    Hum Pathol; 2000 Jun; 31(6):751-60. PubMed ID: 10872671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. p27 expression correlates with prognosis in patients with hypopharyngeal cancer.
    Mineta H; Miura K; Suzuki I; Takebayashi S; Misawa K; Ueda Y; Ichimura K
    Anticancer Res; 1999; 19(5C):4407-12. PubMed ID: 10650784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunohistochemical study of cell cycle-associated proteins in adenocarcinoma of the uterine cervix treated with radiotherapy alone: P53 status has a strong impact on prognosis.
    Suzuki Y; Nakano T; Kato S; Ohno T; Tsujii H; Oka K
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):231-6. PubMed ID: 15337561
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Silibinin suppresses in vivo growth of human prostate carcinoma PC-3 tumor xenograft.
    Singh RP; Deep G; Blouin MJ; Pollak MN; Agarwal R
    Carcinogenesis; 2007 Dec; 28(12):2567-74. PubMed ID: 17916909
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The cell cycle regulator p27kip1 contributes to growth and differentiation of osteoblasts.
    Drissi H; Hushka D; Aslam F; Nguyen Q; Buffone E; Koff A; van Wijnen A; Lian JB; Stein JL; Stein GS
    Cancer Res; 1999 Aug; 59(15):3705-11. PubMed ID: 10446985
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 20-Cyclopropyl-cholecalciferol vitamin D3 analogs: a unique class of potent inhibitors of proliferation of human prostate, breast and myeloid leukemia cell lines.
    Koike M; Koshizuka K; Kawabata H; Yang R; Taub HE; Said J; Uskokovic M; Tsuruoka N; Koeffler HP
    Anticancer Res; 1999; 19(3A):1689-97. PubMed ID: 10470102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression of p27/Kip1 is down-regulated in human prostate carcinoma progression.
    Fernández PL; Arce Y; Farré X; Martínez A; Nadal A; Rey MJ; Peiró N; Campo E; Cardesa A
    J Pathol; 1999 Apr; 187(5):563-6. PubMed ID: 10398122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased p27Kip1 cyclin-dependent kinase inhibitor gene expression following anti-IgM treatment promotes apoptosis of WEHI 231 B cells.
    Wu M; Bellas RE; Shen J; Yang W; Sonenshein GE
    J Immunol; 1999 Dec; 163(12):6530-5. PubMed ID: 10586045
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.